NDC product
Conex Pediatric
NDC 54859-803 · Llorens Pharmaceutical International Division
Key facts
| Product NDC | 54859-803 |
|---|---|
| Proprietary name | Conex Pediatric |
| Nonproprietary name | Dexbrompheniramine Maleate, Pseudoephedrine HCl |
| Substances | DEXBROMPHENIRAMINE MALEATE, PSEUDOEPHEDRINE HYDROCHLORIDE |
| Dosage form | LIQUID |
| Route | ORAL |
| Labeler | Llorens Pharmaceutical International Division |
| Product type | HUMAN OTC DRUG |
| Marketing category | OTC MONOGRAPH DRUG |
| Application number | M012 |
| Pharmacologic classes | Adrenergic alpha-Agonists [MoA], alpha-Adrenergic Agonist [EPC] |
| Marketing start | Dec 1, 2024 |
| Listing certified through | Dec 31, 2026 |
At a glance
- 1–9 Package NDCs
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About National Drug Codes (NDC)
The National Drug Code (NDC) is the FDA's product identifier for drugs; the product NDC identifies the labeler and product, and each package adds a package code.
Source: U.S. Food and Drug Administration (FDA), National Drug Code Directory · Source date: